281 related articles for article (PubMed ID: 11717538)
21. Expression of angiogenesis-related genes in ovarian carcinoma--a clinicopathologic study.
Davidson B; Goldberg I; Kopolovic J; Gotlieb WH; Givant-Horwitz V; Nesland JM; Berner A; Ben-Baruch G; Bryne M; Reich R
Clin Exp Metastasis; 2000; 18(6):501-7. PubMed ID: 11592307
[TBL] [Abstract][Full Text] [Related]
22. Granulin-epithelin precursor is a novel prognostic marker in epithelial ovarian carcinoma.
Davidson B; Alejandro E; Flørenes VA; Goderstad JM; Risberg B; Kristensen GB; Trope CG; Kohn EC
Cancer; 2004 May; 100(10):2139-47. PubMed ID: 15139056
[TBL] [Abstract][Full Text] [Related]
23. The clinical role of phospholipase A2 isoforms in advanced-stage ovarian carcinoma.
Gorovetz M; Baekelandt M; Berner A; Trope' CG; Davidson B; Reich R
Gynecol Oncol; 2006 Dec; 103(3):831-40. PubMed ID: 16919315
[TBL] [Abstract][Full Text] [Related]
24. Invasive properties of serous human epithelial ovarian tumors are related to Ets-1, MMP-1 and MMP-9 expression.
Behrens P; Rothe M; Florin A; Wellmann A; Wernert N
Int J Mol Med; 2001 Aug; 8(2):149-54. PubMed ID: 11445865
[TBL] [Abstract][Full Text] [Related]
25. Argonaute, Dicer, and Drosha are up-regulated along tumor progression in serous ovarian carcinoma.
Vaksman O; Hetland TE; Trope' CG; Reich R; Davidson B
Hum Pathol; 2012 Nov; 43(11):2062-9. PubMed ID: 22647351
[TBL] [Abstract][Full Text] [Related]
26. AZGP1 and SPDEF mRNA expression differentiates breast carcinoma from ovarian serous carcinoma.
Stavnes HT; Nymoen DA; Langerød A; Holth A; Børresen Dale AL; Davidson B
Virchows Arch; 2013 Feb; 462(2):163-73. PubMed ID: 23242172
[TBL] [Abstract][Full Text] [Related]
27. Expression of the 67 kDa laminin receptor and the alpha6 integrin subunit in serous ovarian carcinoma.
Givant-Horwitz V; Davidson B; van de Putte G; Dong HP; Goldberg I; Amir S; Kristensen GB; Reich R
Clin Exp Metastasis; 2003; 20(7):599-609. PubMed ID: 14669791
[TBL] [Abstract][Full Text] [Related]
28. VICKZ2 protein expression in ovarian serous carcinoma effusions is associated with poor survival.
Davidson B; Rosenfeld YB; Holth A; Hellesylt E; Tropé CG; Reich R; Yisraeli JK
Hum Pathol; 2014 Jul; 45(7):1520-8. PubMed ID: 24814803
[TBL] [Abstract][Full Text] [Related]
29. Aurora B expression in metastatic effusions from advanced-stage ovarian serous carcinoma is predictive of intrinsic chemotherapy resistance.
Hetland TE; Nymoen DA; Holth A; Brusegard K; Flørenes VA; Kærn J; Tropé CG; Davidson B
Hum Pathol; 2013 May; 44(5):777-85. PubMed ID: 23114921
[TBL] [Abstract][Full Text] [Related]
30. Mammalian target of rapamycin is a biomarker of poor survival in metastatic serous ovarian carcinoma.
Bunkholt Elstrand M; Dong HP; Ødegaard E; Holth A; Elloul S; Reich R; Tropé CG; Davidson B
Hum Pathol; 2010 Jun; 41(6):794-804. PubMed ID: 20153512
[TBL] [Abstract][Full Text] [Related]
31. HMGA2 protein expression in ovarian serous carcinoma effusions, primary tumors, and solid metastases.
Hetland TE; Holth A; Kærn J; Flørenes VA; Tropé CG; Davidson B
Virchows Arch; 2012 May; 460(5):505-13. PubMed ID: 22476403
[TBL] [Abstract][Full Text] [Related]
32. The prognostic value of metalloproteinases and angiogenic factors in ovarian carcinoma.
Davidson B; Goldberg I; Gotlieb WH; Kopolovic J; Ben-Baruch G; Nesland JM; Reich R
Mol Cell Endocrinol; 2002 Feb; 187(1-2):39-45. PubMed ID: 11988310
[TBL] [Abstract][Full Text] [Related]
33. Caveolin-1 expression in ovarian carcinoma is MDR1 independent.
Davidson B; Goldberg I; Givant-Horwitz V; Nesland JM; Berner A; Bryne M; Risberg B; Kopolovic J; Kristensen GB; Tropé CG; van de Putte G; Reich R
Am J Clin Pathol; 2002 Feb; 117(2):225-34. PubMed ID: 11863219
[TBL] [Abstract][Full Text] [Related]
34. HOXB8 expression in ovarian serous carcinoma effusions is associated with shorter survival.
Stavnes HT; Holth A; Don T; Kærn J; Vaksman O; Reich R; Trope' CG; Davidson B
Gynecol Oncol; 2013 May; 129(2):358-63. PubMed ID: 23438671
[TBL] [Abstract][Full Text] [Related]
35. Expression of metastasis-related genes in human epithelial ovarian tumors.
Herrera CA; Xu L; Bucana CD; Silva el VG; Hess KR; Gershenson DM; Fidler IJ
Int J Oncol; 2002 Jan; 20(1):5-13. PubMed ID: 11743636
[TBL] [Abstract][Full Text] [Related]
36. MUC4 is upregulated in ovarian carcinoma effusions and differentiates carcinoma cells from mesothelial cells.
Davidson B; Baekelandt M; Shih IeM
Diagn Cytopathol; 2007 Dec; 35(12):756-60. PubMed ID: 18008338
[TBL] [Abstract][Full Text] [Related]
37. Heparanase and basic fibroblast growth factor are co-expressed in malignant mesothelioma.
Davidson B; Vintman L; Zcharia E; Bedrossian C; Berner A; Nielsen S; Ilan N; Vlodavsky I; Reich R
Clin Exp Metastasis; 2004; 21(5):469-76. PubMed ID: 15672872
[TBL] [Abstract][Full Text] [Related]
38. [The expression and significance of VEGF mRNA and bFGF mRNA in the malignant neoplasms of ovary].
Li L; Liu YZ; Wu YL
Hunan Yi Ke Da Xue Xue Bao; 2000 Aug; 25(4):406-8. PubMed ID: 12206019
[TBL] [Abstract][Full Text] [Related]
39. Strong expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in ovarian borderline and malignant neoplasms.
Abu-Jawdeh GM; Faix JD; Niloff J; Tognazzi K; Manseau E; Dvorak HF; Brown LF
Lab Invest; 1996 Jun; 74(6):1105-15. PubMed ID: 8667614
[TBL] [Abstract][Full Text] [Related]
40. Ezrin Is Associated with Disease Progression in Ovarian Carcinoma.
Horwitz V; Davidson B; Stern D; Tropé CG; Tavor Re'em T; Reich R
PLoS One; 2016; 11(9):e0162502. PubMed ID: 27622508
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
